子宫移位术后首例活产
一例28岁未产女性因左侧髂部及胸部同步性黏液样低级别脂肪肉瘤行子宫移位术,接受盆腔及胸部放疗后行子宫复位,后自然妊娠并于36周2天剖宫产分娩一男婴,出生体重2686克、身长46.5厘米,Apgar评分5分和9分,母婴次日出院,随访1年婴儿发育正常且患者无复发迹象。
要点
- 子宫移位术为需盆腔放疗患者保留生育力提供可能。
- 放疗后子宫复位,患者自然妊娠并剖宫产分娩活婴。
- 随访1年母婴结局良好,婴儿发育正常且患者无复发。
核心结论
- 据作者所知,本例子宫移位术后首例活产证明子宫移位术作为需盆腔放疗患者预防不孕的手段具有可行性。
研究设计与样本
- 病例报告,设置于三级转诊癌症医院。
- 患者为28岁未产女性,患有左侧髂部及胸部同步性黏液样低级别脂肪肉瘤,已行切除术且切缘近。
主要发现
- 患者于2018年10月25日接受盆腔(60 Gy)及胸部(60 Gy)放疗前先行子宫移位术。
- 放疗后于2019年2月20日将子宫重新植入盆腔。
- 患者于2021年6月妊娠,妊娠过程平稳至36周,出现早产临产并于2022年1月26日行剖宫产分娩。
- 分娩一男婴,孕周36周2天,体重2686克,身长46.5厘米,Apgar评分分别为5分和9分,母婴次日出院。
- 随访1年后,婴儿发育正常,患者无复发迹象。
临床怎么用
- 原文未据此给出推荐,仅报告该病例结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To our knowledge, to report the first case of live birth of a child after uterine transposition (UT), pelvic radiotherapy, and subsequent uterine repositioning. DESIGN: Case report. SETTING: Tertiary referral cancer hospital. PATIENT(S): A 28-year-old nulligravid woman with left iliac and thoracic synchronous myxoid low-grade liposarcoma, which was resected with close margins. INTERVENTION(S): The patient underwent UT before undergoing pelvic (60 Gy) and thoracic (60 Gy) radiation on October 25, 2018. After radiotherapy, her uterus was reimplanted in the pelvis on February 20, 2019. MAIN OUTCOME MEASURE(S): The patient became pregnant in June 2021 and experienced an uneventful pregnancy until 36 weeks, when the patient started preterm labor and had a cesarean section delivery on January 26, 2022. RESULT(S): A boy was delivered after a gestation period of 36 weeks and 2 days (2686 g and 46.5 cm), with Apgar scores of 5 and 9, respectively; both mother and child were discharged the following day. After 1 year of follow-ups, the infant maintained normal development and the patient showed no signs of recurrence. CONCLUSION(S): To our knowledge, this case of the first live birth after UT is a proof-of-concept for the viability of UT as a procedure to prevent infertility in patients requiring pelvic radiotherapy.
引用
- Ribeiro R, Anselmi MC, Schneider GA, et al. First live birth after uterine transposition. Fertil Steril. 2023. PMID: 36863432. doi:10.1016/j.fertnstert.2023.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。